Remove Economics Remove Pharmaceutical Remove Securities
article thumbnail

Monetizing an Earn-Out – Does That Make It a “Security?”

Cooley M&A

Therefore, buyers should be cognizant of these securities law considerations and some of their practical implications. If the right to be paid contingent consideration is transferable, that right will likely be considered a “security” of the buyer under long-held SEC guidance. Private placement. earn-out rights).

article thumbnail

PODCAST REVIEW: ACQUIRING MINDS: How to Buy the Business Where You Work | Corey Veverka Interview

How2Exit

rn About The Guest(s): Corey Veverka is the owner of TBS, a company that specializes in validation and compliance for pharmaceutical manufacturing facilities. rn Financing the deal was a challenge, but Corey was able to secure an SBA loan to acquire the business. New episodes 2x per week.

Business 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Managing Product Shortages through Strategic M&A: Building a Resilient Supply Chain

Sun Acquisitions

These shortages can result from various factors, including natural disasters, geopolitical tensions, economic instability, and unexpected surges in demand. By integrating complementary businesses and resources, M&A can help companies secure more reliable supply chains and ensure consistent product availability.

M&A 52
article thumbnail

Shareholders vs. Stakeholders - Understanding Corporate Responsibilities

Peak Frameworks

For example, in the 2012 Facebook IPO, common shareholders gained exposure to the tech giant's fortunes, while also securing a say in corporate matters. Proponents argue that by fulfilling this responsibility, firms indirectly benefit society by driving economic growth and innovation.

article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40
article thumbnail

Learning Old Lessons From Recent Life Sciences Earnout Disputes: Above All Else, Words Matter

Cooley M&A

Alexion Pharmaceuticals (Del. Alexion Pharmaceuticals , arose out of Alexion’s 2018 acquisition of a company called Syntimmune. Further, the parties should consider whether the economic impact of the potential milestone payments can be taken into account by the buyer in making decisions. In both Fortis v.

article thumbnail

The SaaS Prescription: Healthcare Trends and M&A Insights

Software Equity Group

In 2022 and 2023, a time when M&A transactions in many industries declined due to economic conditions, healthcare M&A deals increased considerably. It enables interoperability between clinical, administrative and financial systems, and makes data more secure.